You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alglucosidase alfa

Showing 1 - 25 of 1,380
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pompe's Disease Trial in China (ALGLUCOSIDASE ALFA)

Recruiting
  • Pompe's Disease
  • ALGLUCOSIDASE ALFA
  • China, China
    Investigational Site
Oct 26, 2022

Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

Completed
Has Results
  • Pompe Disease
  • +2 more
  • alglucosidase alfa
  • Gainesville, Florida
  • +2 more
Jul 29, 2022

Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

Recruiting
  • Glycogen Storage Disease Type II
  • Alglucosidase alfa GZ419829
  • Leuven, Belgium
  • +8 more
Jan 17, 2023

Glycogen Storage Disease Type II-Pompe's Disease Trial in Worldwide (Avalglucosidase alfa (GZ402666), Alglucosidase alfa

Active, not recruiting
Has Results
  • Glycogen Storage Disease Type II-Pompe's Disease
  • Avalglucosidase alfa (GZ402666)
  • Alglucosidase alfa (GZ419829)
  • Valhalla, New York
  • +9 more
May 3, 2022

Pompe Disease Trial in New York, Fairfax (biological, drug, other)

Not yet recruiting
  • Pompe Disease
  • Cipaglucosidase alfa
  • +3 more
  • New York, New York
  • +1 more
Nov 2, 2023

Pompe Disease, Glycogen Storage Disease Type II (GSD II) Trial in Worldwide (alglucosidase alfa)

Completed
Has Results
  • Pompe Disease
  • Glycogen Storage Disease Type II (GSD II)
  • alglucosidase alfa
  • Valhalla, New York
  • +11 more
Mar 15, 2022

Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States

Terminated
Has Results
  • Pompe Disease
  • +2 more
  • Myozyme® (alglucosidase alfa)
  • Louisville, Kentucky
  • +4 more
Mar 24, 2022

Higher Dose of Alglucosidase Alpha for Pompe Disease

Not yet recruiting
  • Glycogen Storage Disease Type II
  • Alglucosidase Alfa
  • (no location specified)
Aug 17, 2021

MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

Recruiting
  • MPS I
  • +8 more
  • Aldurazyme (laronidase)
  • San Francisco, California
    University of California
Apr 21, 2022

Pompe Disease Trial in Worldwide (alglucosidase alfa)

Completed
  • Pompe Disease
  • alglucosidase alfa
  • Phoenix, Arizona
  • +17 more
Jul 12, 2021

Glycogen Storage Disease Type II;Pompe's Disease Trial in Worldwide (Avalglucosidase alfa (GZ402666), Alglucosidase alfa

Active, not recruiting
Has Results
  • Glycogen Storage Disease Type II;Pompe's Disease
  • Avalglucosidase alfa (GZ402666)
  • Alglucosidase alfa (GZ419829)
  • Phoenix, Arizona
  • +68 more
May 3, 2022

Pompe Disease (Late-onset) Trial in Worldwide (AT2221, alglucosidase alfa, ATB200)

Completed
  • Pompe Disease (Late-onset)
  • Phoenix, Arizona
  • +72 more
Oct 7, 2021

Myozyme® and of Aldurazyme® in Male and Female Participants of

Recruiting
  • Pompe Disease
  • Mucopolysaccharidosis Type I (MPS I)
    • Italy, Italy
      Investigational site Italy
    May 3, 2022

    Glycogen Storage Disease Type II Pompe Disease Trial in Worldwide (GZ402666)

    Completed
    • Glycogen Storage Disease Type II Pompe Disease
    • Phoenix, Arizona
    • +16 more
    Dec 14, 2022

    CRIM Status and Longitudinal Follow-up of Individuals With Pompe

    Recruiting
    • Pompe Disease
    • Observational
    • Durham, North Carolina
      Duke University Medical Center
    Sep 16, 2021

    ERT in Pompe Disease: Elucidation of Molecular Structures

    Not yet recruiting
    • Pompe-Disease
      • Rüsselsheim, Hessen, Germany
        Centre for Analytical Biochemistry
      Jan 30, 2023

      Patients With "Late-Onset" Pompe Disease

      Active, not recruiting
      • Pompe Disease
      • +2 more
      • Observational
      • Durham, North Carolina
        Duke University
      Oct 7, 2022

      Pompe Disease Trial in Worldwide (duvoglustat, rhGAA)

      Completed
      Has Results
      • Pompe Disease
      • Phoenix, Arizona
      • +14 more
      Sep 4, 2018

      Pompe Disease, Pompe Disease (Late-onset), Pompe's Disease Juvenile Onset Trial in Erlangen (Multispectral Optoacoustic

      Recruiting
      • Pompe Disease
      • +3 more
      • Multispectral Optoacoustic Tomography
      • Erlangen, Bavaria, Germany
        University Hospital Erlangen
      Jun 2, 2022

      Glycogen Storage Disease Type II, Pompe Disease Trial in Worldwide

      Recruiting
      • Glycogen Storage Disease Type II
      • Pompe Disease
        • Birmingham, Alabama
        • +274 more
        Jan 12, 2023

        Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)

        Not yet recruiting
        • Hypophosphatasia
        • Hartford, Connecticut
        • +29 more
        Oct 6, 2023

        Pompe Disease, Glycogen Storage Disease Type II, Lysosomal Storage Diseases Trial in Gainesville (Diet and Exercise)

        Completed
        • Pompe Disease
        • +2 more
        • Diet and Exercise
        • Gainesville, Florida
          University of Florida Clinical Research Center
        May 13, 2021

        Tarui Disease, Debrancher Deficiency, GYG1 DEFICIENCY Trial in Copenhagen (Triheptanoin, Placebo Oil)

        Terminated
        • Tarui Disease
        • +2 more
        • Copenhagen, Denmark
          Copenhagen Neuromuscular Center
        Aug 4, 2021

        Fabry Disease Under Enzyme Replacement Therapy With

        Recruiting
        • Fabry Disease
        • Berlin, Germany
        • +7 more
        Oct 17, 2023

        Hypophosphatasia Trial in Würzburg (Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg)

        Recruiting
        • Hypophosphatasia
        • Ilofotase Alfa, 0.8 mg/kg
        • Ilofotase Alfa, 3.2 mg/kg
        • Würzburg, Germany
          Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KL
        May 26, 2023